BioSight
Companies
CAPRICOR THERAPEUTICS, INC. logo

CAPR

NASDAQSAN DIEGO, CA
CAPRICOR THERAPEUTICS, INC.

Capricor Therapeutics is a clinical-stage biotech company developing cell therapy and regenerative medicine treatments for cardiovascular and other diseases, with product candidates in various stages of development targeting conditions such as heart disease and related indications. The company focuses on advancing its pipeline through clinical trials while pursuing regulatory approvals and exploring partnerships for manufacturing and commercialization of its therapeutic candidates.

Price history not yet available for CAPR.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar